IL177028A0 - Use of aerosolized antithrombin to treat acute lung injury - Google Patents

Use of aerosolized antithrombin to treat acute lung injury

Info

Publication number
IL177028A0
IL177028A0 IL177028A IL17702806A IL177028A0 IL 177028 A0 IL177028 A0 IL 177028A0 IL 177028 A IL177028 A IL 177028A IL 17702806 A IL17702806 A IL 17702806A IL 177028 A0 IL177028 A0 IL 177028A0
Authority
IL
Israel
Prior art keywords
lung injury
acute lung
treat acute
antithrombin
aerosolized
Prior art date
Application number
IL177028A
Other languages
English (en)
Original Assignee
Gtc Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gtc Biotherapeutics Inc filed Critical Gtc Biotherapeutics Inc
Publication of IL177028A0 publication Critical patent/IL177028A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL177028A 2004-01-23 2006-07-23 Use of aerosolized antithrombin to treat acute lung injury IL177028A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53867804P 2004-01-23 2004-01-23
US11/034,590 US20050169908A1 (en) 2004-01-23 2005-01-13 Use of aerosolized antithrombin to treat acute lung injury
PCT/US2005/001238 WO2005072139A2 (en) 2004-01-23 2005-01-14 Use of aerosolized antithrombin to treat acute lung injury

Publications (1)

Publication Number Publication Date
IL177028A0 true IL177028A0 (en) 2006-12-10

Family

ID=34810485

Family Applications (1)

Application Number Title Priority Date Filing Date
IL177028A IL177028A0 (en) 2004-01-23 2006-07-23 Use of aerosolized antithrombin to treat acute lung injury

Country Status (8)

Country Link
US (1) US20050169908A1 (enExample)
EP (1) EP1713500A2 (enExample)
JP (1) JP4854519B2 (enExample)
KR (1) KR20060127992A (enExample)
AU (1) AU2005208552A1 (enExample)
CA (1) CA2553758A1 (enExample)
IL (1) IL177028A0 (enExample)
WO (1) WO2005072139A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090221475A9 (en) * 2002-04-01 2009-09-03 Kazunori Murakami Treatment of lung disorders
US20050192226A1 (en) * 2004-02-20 2005-09-01 Perenlei Enkhbaatar Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants
US20050245444A1 (en) * 2004-04-30 2005-11-03 Yann Echelard Method of using recombinant human antithrombin for neurocognitive disorders
US20060121004A1 (en) * 2004-12-07 2006-06-08 Yann Echelard Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin
CN103429272A (zh) 2010-12-30 2013-12-04 法国化学与生物科技实验室 作为病原体灭活剂的二元醇
CA2931172C (en) 2012-12-05 2022-11-15 National Jewish Health Treatment for airway cast obstruction
KR20160002713A (ko) 2013-02-13 2016-01-08 라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 고도로 갈락토실화된 항-tnf-알파 항체 및 이의 용도
CN105263319A (zh) 2013-02-13 2016-01-20 法国化学与生物科技实验室 具有经修饰的糖基化的蛋白及其生产方法
MX384222B (es) 2013-07-05 2025-03-14 Lab Francais Du Fractionnement Matriz de cromatografia de afinidad.
JP2016535782A (ja) 2013-11-04 2016-11-17 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 被験者の気道への酵素の投与のための組成物及び方法
EP3247332A1 (en) * 2015-01-20 2017-11-29 Incarda Therapeutics, Inc. Unit aerosol doses for anticoagulation
US20180140547A1 (en) * 2015-05-06 2018-05-24 Board Of Regents, The University Of Texas System Compositions and methods for administration of an enzyme to a subject's airway
FR3038517B1 (fr) 2015-07-06 2020-02-28 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Utilisation de fragments fc modifies en immunotherapie
US11654036B2 (en) 2020-05-26 2023-05-23 Elixir Medical Corporation Anticoagulant compounds and methods and devices for their use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127347A (en) * 1994-01-12 2000-10-03 Univ Michigan Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
US5843705A (en) * 1995-02-21 1998-12-01 Genzyme Transgenic Corporation Transgenically produced antithrombin III
US7045585B2 (en) * 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US6063593A (en) * 1996-11-12 2000-05-16 University Of Southern California University Park Campus TGFβ1 responsive bone marrow derived cells to express a recombinant protein
US6124257A (en) * 1997-08-28 2000-09-26 Lezdey; John Method of treatment
DE10132307A1 (de) * 2001-07-06 2003-01-30 Aventis Behring Gmbh Arzneizubereitung zur Inhalation von Antithrombin bei entzündlichen Lungenerkrankungen und ARDS
US20090221475A9 (en) * 2002-04-01 2009-09-03 Kazunori Murakami Treatment of lung disorders
US20050192226A1 (en) * 2004-02-20 2005-09-01 Perenlei Enkhbaatar Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants

Also Published As

Publication number Publication date
KR20060127992A (ko) 2006-12-13
EP1713500A2 (en) 2006-10-25
JP2007518801A (ja) 2007-07-12
WO2005072139A3 (en) 2006-01-05
US20050169908A1 (en) 2005-08-04
JP4854519B2 (ja) 2012-01-18
WO2005072139A2 (en) 2005-08-11
CA2553758A1 (en) 2005-08-11
AU2005208552A1 (en) 2005-08-11

Similar Documents

Publication Publication Date Title
IL169602A0 (en) Methods of treating lung diseases
EP1692318A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF LUNG CANCER
IL177028A0 (en) Use of aerosolized antithrombin to treat acute lung injury
GB2453188B (en) Use of compounds in the manufacture of medicaments for treatment of regional fat deposits
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
EP2214712A4 (en) COMPOSITIONS AND METHODS FOR TREATING ASTHMA AND PULMONARY DISORDERS
PL2546253T3 (pl) Podstawione dihydropirazolony do leczenia schorzeń sercowo-naczyniowych i hematologicznych
PL2170848T3 (pl) Pochodne pirazynonu i ich zastosowanie w leczeniu chorób płuc
GB2410919B (en) Improvements in or relating to the treatment of waste
ZA200709520B (en) Use of TFPI to treat severe bacterial infections
GB0410399D0 (en) The treatment of respiratory disease
ZA200609967B (en) Treating respiratory diseases with glycopyrrolate and analogues
NO20054767D0 (no) Sammensetninger omfattende apomorfin for inhalering i lunge
IL164078A0 (en) Treatment of lung disorder
ZA200609141B (en) Compositions for Inhalation therapy and methods of use
WO2009006246A8 (en) Use of tight junction antagonists in the treatment of acute long injury and acute respiratory distress syndrome
EP1765331A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY DISEASES
EP1737475A4 (en) VEGETABLE THERAPY FOR THE TREATMENT OF ASTHMA
SG113539A1 (en) He treatment to improve low-k adhesion property
PL1656949T3 (pl) Zastosowanie alfa-1 antytrypsyny do wytwarzania leków do leczenia fibromialgii
IL172528A0 (en) Surface treatment of sars-infected lungs
GB0524959D0 (en) Topical compositions for treatment of respiratory disorders
EP1871404A4 (en) ANTI-ASTHMATIC TREATMENT
IL155737A0 (en) Enriched air for treating lung diseases
GB0612748D0 (en) Treatment and/or prevention of inflammatory lung disease